Literature DB >> 9789678

Renal medullary rim sign in 2 adult quarter horses.

S Ramirez1, T L Seahorn, J Williams.   

Abstract

This report describes a renal ultrasonographic abnormality (medullary rim sign), which was identified in 2 separate cases of spontaneously occurring disease associated with chronic and acute overdosage of phenylbutazone therapy. In horses, medullary rim sign has only been documented in neonatal foals experimentally administered large doses of phenylbutazone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9789678      PMCID: PMC1539447     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  6 in total

1.  Ultrasonographic renal changes associated with phenylbutazone administration in three foals.

Authors:  R Léveillé; T Miyabayashi; S E Weisbrode; D S Biller; M Takiguchi; J F Williams
Journal:  Can Vet J       Date:  1996-04       Impact factor: 1.008

2.  Study of association between histologic features and echogenicity of architecturally normal cat kidneys.

Authors:  A E Yeager; W I Anderson
Journal:  Am J Vet Res       Date:  1989-06       Impact factor: 1.156

3.  Early renal ultrasonographic findings in dogs with experimentally induced ethylene glycol nephrosis.

Authors:  W H Adams; R L Toal; M A Walker; M A Breider
Journal:  Am J Vet Res       Date:  1989-08       Impact factor: 1.156

4.  Renal papillary necrosis in horses.

Authors:  D E Gunson
Journal:  J Am Vet Med Assoc       Date:  1983-02-01       Impact factor: 1.936

5.  Hyperechogenic "rings" in the periphery of renal medullary pyramids as a sign of renal disease.

Authors:  M J Päivänsalo; M J Kallioinen; J S Merikanto; P K Jalovaara
Journal:  J Clin Ultrasound       Date:  1991-06       Impact factor: 0.910

6.  Ultrasonographic findings in dogs and cats with oxalate nephrosis attributed to ethylene glycol intoxication: 15 cases (1984-1988).

Authors:  W H Adams; R L Toal; M A Breider
Journal:  J Am Vet Med Assoc       Date:  1991-08-15       Impact factor: 1.936

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.